Biggest News Aggregation in the World
📰 Joint Representatives News

Joint Representatives News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Joint Representatives. Real-time updates on events, politics, business and more.

Investegate |G&P GmbH & Co.KG Announcements | G&P GmbH & Co.KG: SolarWorld AG Sales proceeds from a sale of Zinnwald Lithium plc shares - Request for information for bondholders who do not receive a delivery of shares

Investegate announcements from G&P GmbH & Co.KG, SolarWorld AG Sales proceeds from a sale of Zinnwald Lithium plc shares - Request for information for bondholders who do not receive a delivery of shares
Alexander Elsmann Gp Gmbh Co Joint Representatives One Square Investegate Announcements Investegate Company Announcements

Weibo Announces Pricing of Global Offering

BEIJING, Dec. 2, 2021 /PRNewswire/ -- Weibo Corporation ("Weibo" or the "Company") (Nasdaq: WB), a leading social media platform in China, today announced the pricing of the global offering (the "Global Offering") of an aggregate of 11,000,000 Class A ordinary shares of the Company. Weibo is offering 5,500,000 Class A ordinary shares of the Company (the "New Shares") and...
New York United States Hong Kong Goldman Sachs Asia Prnewswire Weibo Corporation Capital Markets

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

TodayIR: Zhaoke Ophthalmology Limited (6622) Successfully listed on the Main Board of SEHK

TodayIR: Zhaoke Ophthalmology Limited (6622) Successfully listed on the Main Board of SEHK DJ EQS-News: Zhaoke Ophthalmology Limited (6622) Successfully listed on the Main Board of SEHK EQS-News / 29/04/2021 / 12:16 UTC+8 Zhaoke Ophthalmology(6622) Successfully Listed on Main Board of SEHK [April 29, 2021, Hong Kong] Zhaoke Ophthalmology Limited ("Zhaoke Ophthalmology" or the "Company"; stock code: 6622), an ophthalmic pharmaceutical company dedicated to the research, development and comme...
Hong Kong Li Xiaoyi Lee Pharm Kostenloser Wertpapierhandel Goldman Sachs Asia Marketing Press

Zhaoke Ophthalmology Limited (6622.HK) Announces Proposed Listing on the Main Board of SEHK_Final

  Zhaoke Ophthalmology is an ophthalmic pharmaceutical company dedicated to the research, development and commercialization of therapies that address significant unmet medical needs in China. Leveraging its deep domain expertise while designing the pipeline, the Company has initially placed strategic emphasis on five major ophthalmic indications in China in terms of market potential, including dry eye disease, or DED, wet age-related macular degeneration, or wAMD, diabetic macular edema, or DM...
United States Hong Kong Li Xiaoyi Goldman Sachs Asia Matthews International Capital Management Golden Valley Global
Source: dgap.de

TodayIR: Zhaoke Ophthalmology Limited (6622.HK) Announces Proposed Listing on the Main Board of SEHK_Final

TodayIR: Zhaoke Ophthalmology Limited (6622.HK) Announces Proposed Listing on the Main Board of SEHK_Final DJ EQS-News: Zhaoke Ophthalmology Limited (6622.HK) Announces Proposed Listing on the Main Board of SEHK_Final EQS-News / 16/04/2021 / 11:26 UTC+8 Zhaoke Ophthalmology Limited (6622.HK) Launches Its HKPO with 8 Cornerstone Investors to Fuel Its Future Growth (April 16, 2021, Hong Kong) Zhaoke Ophthalmology Limited ("Zhaoke Ophthalmology" or the "Company"; stock code: 6622), an ophthal...
United States Hong Kong Li Xiaoyi Kostenloser Wertpapierhandel Goldman Sachs Asia Matthews International Capital Management

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science